Encycle Therapeutics Overview
- Year Founded
-
2012
- Status
-
Acquired/Merged
- Employees
-
6
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$80M
Encycle Therapeutics General Information
Description
Developer of drugs designed to exploit a novel synthetic method to generate drug-like cyclic peptides. The company's drugs are generated by several scaffolds that are membrane-permeable and orally bioavailable products thereby, enabling patients to get cured of inflammatory bowel disease and other inflammatory disorders.
Contact Information
Website
www.encycletherapeutics.comCorporate Office
- 101 College Street
- Suite 314
- Toronto, Ontario M5G 1L7
- Canada
Corporate Office
- 101 College Street
- Suite 314
- Toronto, Ontario M5G 1L7
- Canada
Encycle Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 7. Merger/Acquisition | 22-Oct-2019 | $80M | Completed | Generating Revenue | ||
| 6. Corporate | 01-Nov-2017 | Completed | Generating Revenue | |||
| 5. Early Stage VC | 30-Sep-2015 | Completed | Startup | |||
| 4. Early Stage VC | 16-Jun-2015 | Completed | Startup | |||
| 3. Grant | 17-Nov-2014 | Completed | Startup | |||
| 2. Early Stage VC | 11-Nov-2014 | $2.5M | $2.5M | Completed | Startup | |
| 1. University Spin-Out | 01-Jan-2012 | Completed | Startup |
Encycle Therapeutics Comparisons
Industry
Financing
Details
Encycle Therapeutics Competitors (16)
One of Encycle Therapeutics’s 16 competitors is Oncorus, a Formerly VC-backed company based in Andover, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Oncorus | Formerly VC-backed | Andover, MA | ||||
| Apeptico | Formerly VC-backed | Vienna, Austria | ||||
| Circle Pharma | Venture Capital-Backed | South San Francisco, CA | ||||
| Rein Therapeutics | Formerly VC-backed | Austin, TX | ||||
| Akari Therapeutics | Formerly VC-backed | London, United Kingdom |
Encycle Therapeutics Patents
Encycle Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2018205008-A1 | Homodetic cyclic peptides targeting α4β7 1ntegrin | Inactive | 10-May-2017 | ||
| WO-2018085921-A1 | Cyclic peptides multimers targeting α4β7 integrin | Inactive | 11-Nov-2016 | ||
| WO-2017079820-A1 | Cyclic peptides targeting α4β7 integrin | Inactive | 11-Nov-2015 | ||
| WO-2017079821-A1 | Fragment synthesis of cyclic peptides | Inactive | 11-Nov-2015 | ||
| CA-2967750-A1 | Solid phase synthesis of cyclic amino acid molecules | Inactive | 19-Nov-2014 | C07K1/1077 |
Encycle Therapeutics Signals
Encycle Therapeutics Former Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Accel-Rx | Accelerator/Incubator | Minority | ||
| BDC Capital | Growth/Expansion | Minority | ||
| CQDM | Not-For-Profit Venture Capital | Minority | ||
| MaRS Investment Accelerator Fund | Venture Capital | Minority | ||
| Merck & Co. | Corporation |
Encycle Therapeutics FAQs
-
When was Encycle Therapeutics founded?
Encycle Therapeutics was founded in 2012.
-
Where is Encycle Therapeutics headquartered?
Encycle Therapeutics is headquartered in Toronto, Canada.
-
What is the size of Encycle Therapeutics?
Encycle Therapeutics has 6 total employees.
-
What industry is Encycle Therapeutics in?
Encycle Therapeutics’s primary industry is Drug Discovery.
-
Is Encycle Therapeutics a private or public company?
Encycle Therapeutics is a Private company.
-
What is the current valuation of Encycle Therapeutics?
The current valuation of Encycle Therapeutics is .
-
What is Encycle Therapeutics’s current revenue?
The current revenue for Encycle Therapeutics is .
-
How much funding has Encycle Therapeutics raised over time?
Encycle Therapeutics has raised $5.99M.
-
Who are Encycle Therapeutics’s investors?
Accel-Rx, BDC Capital, CQDM, MaRS Investment Accelerator Fund, and Merck & Co. are 5 of 10 investors who have invested in Encycle Therapeutics.
-
Who are Encycle Therapeutics’s competitors?
Oncorus, Apeptico, Circle Pharma, Rein Therapeutics, and Akari Therapeutics are some of the 16 competitors of Encycle Therapeutics.
-
When was Encycle Therapeutics acquired?
Encycle Therapeutics was acquired on 22-Oct-2019.
-
Who acquired Encycle Therapeutics?
Encycle Therapeutics was acquired by Zealand Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process